StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors.
StimOxyGen has raised $1.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
StimOxyGen's investors include Innovate UK, DSW Ventures, Clarendon Fund Managers, QUBIS.
StimOxyGen is headquartered in Coleraine, United Kingdom.
StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors.
StimOxyGen is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StimOxyGen — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/stimoxygen. Accessed November 14, 2026.
VCBacked. (2025). StimOxyGen — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/stimoxygen
{{cite web |title=StimOxyGen — Funding & Investors |url=https://www.vcbacked.co/company/stimoxygen |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at StimOxyGen? Request a listing update